The company was founded in 2003 and is headquartered in San Diego, California.
Similarly, What sector is BNGO in?
Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space.
Is BNGO a pump and dump? BNGO stock has suffered at the hands of a Ritalin-using pump and dump scheme making waves in 2021.
Thereof, How many employees does BNGO have?
Compare BNGO With Other Stocks
| Bionano Genomics Annual Number of Employees | |
|---|---|
| 2020 | 147 |
| 2019 | 97 |
| 2018 | 77 |
| 2017 | 65 |
Who are Bionano genomics competitors?
13 Competitors
BioNano Genomics’s competitors are BioDiscovery, Fluxion Biosciences, IRX Therapeutics, Hepregen, Genvault Corporation and more.
Who is BNGO stock?
(BNGO) Stock Price, News, Quote & History – Yahoo Finance.
…
Performance Outlook.
| Previous Close | 2.3200 |
|---|---|
| Bid | 2.1800 x 27000 |
| Ask | 2.2300 x 29200 |
| Day’s Range | 2.1800 – 2.3200 |
| 52 Week Range | 1.6200 – 9.1200 |
Is BNGO in Russell?
(Nasdaq: BNGO) announced today that it was added as a member of the US small-cap Russell 2000® Index, effective after the US market opens on Monday, June 28, 2021, as part of the 2021 Russell indexes reconstitution.
How do I buy BNGO stock?
How to Buy BNGO Stock
- Pick a brokerage. Retail investors like yourself are buying stocks through the brokers. …
- Decide how many shares you want. After you open and fund your brokerage account you’re ready to buy the shares. …
- Choose your order type. …
- Execute your trade.
Is BNGO a meme stock?
Admittedly, it has been a while since Bionano Genomics (NASDAQ:BNGO) stock has been a “hot stock,” a “meme stock” or whatever you want to call it. Since its big drop in late February and early March, the market has had mixed feelings about this life sciences company.
Who owns Bionano genomics?
Top 10 Owners of Bionano Genomics Inc
| Stockholder | Stake | Shares owned |
|---|---|---|
| BlackRock Fund Advisors | 5.74% | 16,609,007 |
| The Vanguard Group, Inc. | 4.86% | 14,064,639 |
| SSgA Funds Management, Inc. | 2.49% | 7,198,880 |
| Geode Capital Management LLC | 1.63% | 4,714,883 |
Will Bionano stock go up?
Bionano Genomics Inc (NASDAQ:BNGO)
The 4 analysts offering 12-month price forecasts for Bionano Genomics Inc have a median target of 7.50, with a high estimate of 14.00 and a low estimate of 6.00. The median estimate represents a +253.77% increase from the last price of 2.12.
Who owns BioNano genomics?
Top 10 Owners of Bionano Genomics Inc
| Stockholder | Stake | Shares owned |
|---|---|---|
| BlackRock Fund Advisors | 5.74% | 16,609,007 |
| The Vanguard Group, Inc. | 4.86% | 14,064,639 |
| SSgA Funds Management, Inc. | 2.49% | 7,198,880 |
| Geode Capital Management LLC | 1.63% | 4,714,883 |
Is BNGO expected to rise?
Bionano Genomics Inc (NASDAQ:BNGO)
The 4 analysts offering 12-month price forecasts for Bionano Genomics Inc have a median target of 7.50, with a high estimate of 14.00 and a low estimate of 6.00. The median estimate represents a +253.77% increase from the last price of 2.12.
Is BNGO in ETF?
Bionano Genomics is a life sciences instrumentation company in the genome analysis space.
…
| ETF | BNGO |
|---|---|
| Shares Out. | 289.18M |
| Market Cap. | 615.96M |
| Div/Shr | 0.00 |
| Div Yield | 0.00 |
Is BNGO in any ETFs?
ETF.com Insight
Bionano Genomics, Inc. is a company in the U.S. stock market and it is a holding in 30 U.S.-traded ETFs. BNGO has around 17.2M shares in the U.S. ETF market. The largest ETF holder of BNGO is the iShares Russell 2000 ETF (IWM), with approximately 6.72M shares.
Does Vanguard hold BNGO?
Institutional investors purchased a net $3.1 million shares of BNGO during the quarter ended March 2019.
…
Top 10 Mutual Funds Holding Bionano Genomics Inc.
| Mutual fund | Vanguard Russell 2000 Index Fund |
|---|---|
| Shares owned | 788,843 |
| Total value ($) | 1,688,124 |
| Shares bought / sold | +33,379 |
| Total change | +4.42% |
How much will BNGO go up?
Stock Price Forecast
The 3 analysts offering 12-month price forecasts for Bionano Genomics Inc have a median target of 8.00, with a high estimate of 14.00 and a low estimate of 6.00. The median estimate represents a +208.29% increase from the last price of 2.60.
Does Cathie own BNGO?
Is Cathie Wood Invested in BNGO? As of the time of this writing, it does not appear that Cathie Wood or ARK are invested in Bionano Genomics. The firm’s genomics and biomedical ETF, ARKG, currently contains 52 individual holdings.
What institutions are buying BNGO?
Bionano Genomics (NASDAQ:BNGO) Institutional Buying and Selling
| Reporting Date | Hedge Fund | Ownership in Company |
|---|---|---|
| 2/14/2022 | Nuveen Asset Management LLC | 0.357% |
| 2/14/2022 | Barclays PLC | 0.123% |
| 2/14/2022 | GSA Capital Partners LLP | 0.019% |
| 2/14/2022 | Mutual Advisors LLC | 0.017% |
What institutions are buying NIO?
Largest shareholders include Baillie Gifford & Co, BlackRock Inc., Vanguard Group Inc, State Street Corp, VWIGX – Vanguard International Growth Fund Investor Shares, Susquehanna International Group, Llp, Goldman Sachs Group Inc, Citadel Advisors Llc, VEIEX – Vanguard Emerging Markets Stock Index Fund Investor Shares, …
How many shares of BNGO are there?
Share Statistics
| Avg Vol (3 month) 3 | 8.16M |
|---|---|
| Shares Outstanding 5 | 289.61M |
| Implied Shares Outstanding 6 | N/A |
| Float 8 | 283.64M |
| % Held by Insiders 1 | 2.17% |
Join TheMoney.co community and don’t forget to share this post !
